JP2025519106A5 - - Google Patents

Info

Publication number
JP2025519106A5
JP2025519106A5 JP2024569222A JP2024569222A JP2025519106A5 JP 2025519106 A5 JP2025519106 A5 JP 2025519106A5 JP 2024569222 A JP2024569222 A JP 2024569222A JP 2024569222 A JP2024569222 A JP 2024569222A JP 2025519106 A5 JP2025519106 A5 JP 2025519106A5
Authority
JP
Japan
Prior art keywords
cells
apolipoprotein
lipid
modified
lipid nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024569222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025519106A (ja
Filing date
Publication date
Priority claimed from PCT/EP2022/076593 external-priority patent/WO2023046931A1/en
Application filed filed Critical
Priority claimed from PCT/EP2023/063967 external-priority patent/WO2023227682A1/en
Publication of JP2025519106A publication Critical patent/JP2025519106A/ja
Publication of JP2025519106A5 publication Critical patent/JP2025519106A5/ja
Pending legal-status Critical Current

Links

JP2024569222A 2022-05-24 2023-05-24 脂質ナノ粒子用のターゲティング体を有する修飾アポリポタンパク質 Pending JP2025519106A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NL2031977 2022-05-24
NL2031977 2022-05-24
EPPCT/EP2022/076593 2022-09-23
PCT/EP2022/076593 WO2023046931A1 (en) 2021-09-23 2022-09-23 Apolipoprotein fusion proteins for cell-specific immune regulation
EP23165273.6 2023-03-29
EP23165273 2023-03-29
PCT/EP2023/063967 WO2023227682A1 (en) 2022-05-24 2023-05-24 Modified apolipoproteins with a targeting body for lipid nanoparticles

Publications (2)

Publication Number Publication Date
JP2025519106A JP2025519106A (ja) 2025-06-24
JP2025519106A5 true JP2025519106A5 (cg-RX-API-DMAC7.html) 2026-04-03

Family

ID=99799287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024569222A Pending JP2025519106A (ja) 2022-05-24 2023-05-24 脂質ナノ粒子用のターゲティング体を有する修飾アポリポタンパク質

Country Status (10)

Country Link
US (1) US20260041638A1 (cg-RX-API-DMAC7.html)
EP (1) EP4532026A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025519106A (cg-RX-API-DMAC7.html)
KR (1) KR20250029793A (cg-RX-API-DMAC7.html)
CN (1) CN119546627A (cg-RX-API-DMAC7.html)
AU (1) AU2023277740A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254811A1 (cg-RX-API-DMAC7.html)
IL (1) IL317201A (cg-RX-API-DMAC7.html)
MX (1) MX2024014330A (cg-RX-API-DMAC7.html)
WO (1) WO2023227682A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343429B2 (en) 2023-10-05 2025-07-01 Nanovation Therapeutics Inc. Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof
WO2025190968A1 (en) 2024-03-11 2025-09-18 Bio-Trip B.V. Apolipoprotein lipid nanoparticle
CN119499247A (zh) * 2024-11-22 2025-02-25 中国农业大学 一种改善或治疗肠道炎症的双载药重组高密度脂蛋白纳米颗粒及其制备方法和应用
CN121059567A (zh) * 2025-11-07 2025-12-05 中国医学科学院输血研究所 一种脂质纳米颗粒及其应用、药物递送载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013125769A1 (ko) * 2012-02-24 2013-08-29 성균관대학교 산학협력단 아포리포단백질을 포함하는 항체-약물 결합체
CN107969127B (zh) * 2015-09-08 2022-09-06 赛瑞品股份有限公司 Apoa-1融合多肽及相关组合物和方法
MX2023014901A (es) 2021-06-22 2024-04-29 Bio Trip B V Nanoparticulas que contienen acido nucleico.

Similar Documents

Publication Publication Date Title
JP7676472B2 (ja) 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体
US20240166721A1 (en) Cd33 exon 2 deficient donor stem cells for use with cd33 targeting agents
JP2022058776A (ja) 系統特異的抗原の阻害のための組成物および方法
CN104936977B (zh) 微管修饰化合物
CN119816517A (zh) 编码靶向bcma的嵌合抗原受体的环状rna
JP2022517618A (ja) 系統特異的抗原の阻害のための組成物および方法
US20260041638A1 (en) Modified apolipoproteins with a targeting body for lipid nanoparticles
CN120390656A (zh) 环状rna组合物
Streit et al. Variable effects of the conserved RNA hairpin element upon 3′ end processing of histone pre-mRNA in vitro
JP2023528415A (ja) Crisprベースの塩基エディターシステムを使用した系列特異的抗原の阻害のための組成物及び方法
JP2023537048A (ja) 遺伝子改変したt細胞の濃縮方法
EP4430186A1 (en) Compositions and methods for erm2 modification
WO2025096878A9 (en) Rna for in vivo transfection with increased expression
JP2023550355A (ja) キメラ抗原受容体を発現する遺伝子操作された細胞に関連する方法および組成物
US20250375522A1 (en) Chimeric checkpoint receptor for the use in treatment of malignant b-cell diseases
WO2024152962A1 (zh) 抗tt3的人源化抗体及其应用
RU2793803C2 (ru) Иммунологически отличимые варианты поверхности клеток для применения в клеточной терапии
WO2025079599A1 (ja) サブセットレベルで細胞を標的化可能な担体およびその製造方法
KR20260062923A (ko) 항-vista 항체 rna 또는 핵산 접합체(arc 또는 anc), 이를 함유하는 조성물 및 이의 치료 용도
HK40014655A (en) Immunologically discernible cell surface variants for use in cell therapy
HK40014655B (en) Immunologically discernible cell surface variants for use in cell therapy